Aptar Pharma Highlights Pharma Services Platform At Cphi Worldwide

aptar Pharma Highlights Pharma Services Platform At Cphi Worldwide
aptar Pharma Highlights Pharma Services Platform At Cphi Worldwide

Aptar Pharma Highlights Pharma Services Platform At Cphi Worldwide Aptar pharma is pleased to be an exhibitor once again at cphi worldwide 2019, which will take place november 5 7 in frankfurt, germany. at stand 111d70, aptar pharma will showcase its diverse portfolio of drug delivery systems, components and active packaging solutions including their latest innovations across nasal, pulmonary, eye care, injectables and dermal drug delivery routes. 16 may 2023. aptar pharma highlights innovative drug delivery solutions at cphi europe. aptar pharma is delighted to announce its participation in the highly anticipated cphi europe event, scheduled to take place from october 24th to 26th, 2023, in barcelona, spain. as a leading provider of advanced drug delivery systems and solutions, we will.

aptar pharma highlights Expanded services platform Product Info
aptar pharma highlights Expanded services platform Product Info

Aptar Pharma Highlights Expanded Services Platform Product Info Innovation tours on november 6 and 7, and has been entered in the 2019 cphi pharma awards. aptar pharma’s newly expanded aptar pharma services platform will be introduced at this year’s cphi. offering early stage to commercialization services, aptar pharma has over 25 years’ experience supporting regulatory submissions. Aptar pharma, a leading drug delivery systems provider, is pleased to be exhibiting at cphi worldwide 2019, the world's largest pharmaceutical exhibition. New fda approved combination product with aptar pharma's vp3 nasal spray system. aptar pharma, a global leader in drug delivery systems, services and active material science solutions, today announced that its vp3 multidose device is the delivery system for glenmark’s ryaltris™ nasal spray, which recently received new drug application (nda) approval by the u.s. food and drug administration. Designed for recyclability, and based on aptar pharma’s proven advanced preservative free (apf) technology platform, apf futurity™ is a finalist in the cphi pharma awards 2023 sustainability category. winners of this year’s awards will be announced at the cphi pharma awards & networking party on october 24.

aptar pharma Key Exhibitor at Cphi Frankfurt 2022 aptar
aptar pharma Key Exhibitor at Cphi Frankfurt 2022 aptar

Aptar Pharma Key Exhibitor At Cphi Frankfurt 2022 Aptar New fda approved combination product with aptar pharma's vp3 nasal spray system. aptar pharma, a global leader in drug delivery systems, services and active material science solutions, today announced that its vp3 multidose device is the delivery system for glenmark’s ryaltris™ nasal spray, which recently received new drug application (nda) approval by the u.s. food and drug administration. Designed for recyclability, and based on aptar pharma’s proven advanced preservative free (apf) technology platform, apf futurity™ is a finalist in the cphi pharma awards 2023 sustainability category. winners of this year’s awards will be announced at the cphi pharma awards & networking party on october 24. Recognized as the world’s largest pharma event, more than 47,000 visitors and 1,800 exhibitors from over 150 countries are expected to attend cphi barcelona 2023. about aptar pharma . aptar pharma is part of aptargroup, inc., a global leader in drug and consumer product dosing, dispensing and protection technologies. Aptar pharma, a leading drug delivery systems provider, is pleased to showcase its commitment to meeting new market trends at cphi worldwide this year. the world’s largest pharma trade show, held 9 – 11 october in madrid, will see more than 100,000 pharmaceutical professionals coming together for exhibitions, conferences and online communities, and this year aptar pharma will be showcasing.

aptar pharma highlights Expanded services platform Product Info
aptar pharma highlights Expanded services platform Product Info

Aptar Pharma Highlights Expanded Services Platform Product Info Recognized as the world’s largest pharma event, more than 47,000 visitors and 1,800 exhibitors from over 150 countries are expected to attend cphi barcelona 2023. about aptar pharma . aptar pharma is part of aptargroup, inc., a global leader in drug and consumer product dosing, dispensing and protection technologies. Aptar pharma, a leading drug delivery systems provider, is pleased to showcase its commitment to meeting new market trends at cphi worldwide this year. the world’s largest pharma trade show, held 9 – 11 october in madrid, will see more than 100,000 pharmaceutical professionals coming together for exhibitions, conferences and online communities, and this year aptar pharma will be showcasing.

cphi worldwide 2020
cphi worldwide 2020

Cphi Worldwide 2020

Comments are closed.